New data show risk-based and centralized monitoring shifts effort across roles, sites, and timelines, reshaping how sponsors plan CRA capacity needs.
|Articles|October 4, 2021
Water: Exactly Where You Need It - Podcast and Q&A
Author(s)Sartorius
In many laboratories, space is at a premium. Especially when centralized laboratory water systems are required to dispense pure and ultrapure water for your applications. To maximize your lab space capabilities, you shouldn’t have to adapt your water system to the laboratory. The system should adapt to your needs. In addition to being economical in terms of its footprint, flexibility in dispensing water is essential. Users need full control over quality parameters at the point of use and the ability to fill different sized containers at the same time across the lab. Sartorius will discuss an innovative and flexible lab water solution that addresses all of these requirements.
Related to this article
Laru-zova helped 31% of high-dose patients gain 15+ letters of vision, representing the first pivotal trial to succeed in treating XLRP.
Telix will acquire ITM for $1.65 billion, gaining a phase 3-validated therapy that cut GEP-NET progression risk versus everolimus.
mAbxience and Sandoz are targeting a $5.7 billion market with a proposed emicizumab biosimilar for hemophilia A.
Fayuvi scored 23.5 points higher than untreated peers on cognitive testing, backing the first-ever approval for a Sanfilippo syndrome A gene therapy.
Athenecia Faggins of Minaris Advanced Therapies discusses raw material qualification, supplier management, testing, and risk control for advanced therapy manufacturing.
FDA compliance officers detailed 2026 guidance updates, online drug sale enforcement, and a first-of-its-kind AI-related warning letter at the PDA/FDA Joint Regulatory Conference.
Sanofi’s Jack Prior discusses how biopharmaceutical manufacturers can assess whether process data is ready for human and AI use, and the role of data quality, accessibility, governance, and AI in manufacturing.